Cargando…
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide epidemic of the lethal respiratory coronavirus disease (COVID-19), necessitating urgent development of specific and effective therapeutic tools. Among several therapeutic targets of coronaviruses, the spike...
Autores principales: | Wang, Lin, Zhou, Junhu, Wang, Qixue, Wang, Yunfei, Kang, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738867/ https://www.ncbi.nlm.nih.gov/pubmed/33391497 http://dx.doi.org/10.7150/thno.51479 |
Ejemplares similares
-
Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
por: Wu, Ye, et al.
Publicado: (2023) -
The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
por: Wang, Qixue, et al.
Publicado: (2019) -
Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019)
por: Wang, Qixue, et al.
Publicado: (2019) -
Expert opinion on translational research for advanced glioblastoma treatment
por: Cui, Xiaoteng, et al.
Publicado: (2023) -
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting
por: Khan, Wahab A., et al.
Publicado: (2021)